About: covid:PMC7332925

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7332925 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Smith, Zachary Peters, Michael Ramesh, Mayur Swiderek, Jennifer Vahia, Amit Bianchini, Monica Johnson, Joseph Griebe, Kristin Hencken, Laura Jones, Mathew Morrison, Austin Stine, John To, Long
is schema:about of	named entity 'SURVIVAL' named entity 'Clinical characteristics' named entity 'tocilizumab' named entity 'ARDS' named entity 'COVID' named entity 'tocilizumab' named entity 'intensive care unit' named entity 'COVID-19' named entity '13.8' named entity 'off-label' named entity 'ribavirin' named entity 'ICU' named entity 'study population' named entity 'SARS-CoV-2' named entity 'CRS' named entity 'COVID-19' named entity 'Categorical data' named entity 'fraction of inspired oxygen' named entity 'hemophagocytic lymphohistiocytosis' named entity 'antimicrobial' named entity 'CRP' named entity 'asymptomatic' named entity 'polymerase-chain-reaction' named entity 'immunomodulator' named entity 'tocilizumab' named entity 'reverse-transcriptase' named entity 'case report form' named entity 'tocilizumab' named entity 'follow-up' named entity 'COVID' named entity 'COVID' named entity 'critically ill' named entity 'adverse drug effects' named entity 'nasal cannula' named entity 'ferritin' named entity 'ECMO' named entity 'LDH' named entity 'supplemental oxygen' named entity 'obesity' named entity 'tocilizumab' named entity 'antagonist' named entity 'tocilizumab' named entity 'off-label' named entity 'tocilizumab' named entity 'Infection' named entity 'lung' named entity 'comorbidity' named entity 'IL-1 receptor antagonist' named entity 'tocilizumab' named entity 'immunomodulatory' named entity 'viral infections' named entity 'CRS' named entity 'adverse effects' named entity 'COVID' named entity 'monotherapy' named entity 'SOFA score' named entity 'amylase' named entity 'supplemental oxygen' named entity 'SOFA score' named entity 'ritonavir' named entity 'tocilizumab' named entity 'symptom' named entity 'chest radiograph' named entity 'IBM' named entity 'SOFA score' named entity 'tocilizumab' named entity 'SOFA score' named entity 'symptom' named entity 'off-label' named entity 'IL-6' named entity 'chi-squared test' named entity 'acute respiratory distress syndrome' named entity 'IL-6 receptor' named entity 'retrospective cohort study' named entity '7-11' named entity 'SOFA score' named entity 'sample size' named entity 'host response' named entity 'Pharmacologic treatment' named entity 'multivariate regression model' named entity 'tocilizumab' named entity 'clinical symptoms' named entity 'tocilizumab' named entity 'tocilizumab' named entity 'LDH' named entity 'invasive mechanical ventilation' named entity 'supplemental oxygen'

Attributes

Values

Creator

Smith, Zachary
Peters, Michael
Ramesh, Mayur
Swiderek, Jennifer
Vahia, Amit
Bianchini, Monica
Johnson, Joseph
Griebe, Kristin
Hencken, Laura
Jones, Mathew
Morrison, Austin
Stine, John
To, Long

is schema:about of

named entity 'SURVIVAL'
named entity 'Clinical characteristics'
named entity 'tocilizumab'
named entity 'ARDS'
named entity 'COVID'
named entity 'tocilizumab'
named entity 'intensive care unit'
named entity 'COVID-19'
named entity '13.8'
named entity 'off-label'
named entity 'ribavirin'
named entity 'ICU'
named entity 'study population'
named entity 'SARS-CoV-2'
named entity 'CRS'
named entity 'COVID-19'
named entity 'Categorical data'
named entity 'fraction of inspired oxygen'
named entity 'hemophagocytic lymphohistiocytosis'
named entity 'antimicrobial'
named entity 'CRP'
named entity 'asymptomatic'
named entity 'polymerase-chain-reaction'
named entity 'immunomodulator'
named entity 'tocilizumab'
named entity 'reverse-transcriptase'
named entity 'case report form'
named entity 'tocilizumab'
named entity 'follow-up'
named entity 'COVID'
named entity 'COVID'
named entity 'critically ill'
named entity 'adverse drug effects'
named entity 'nasal cannula'
named entity 'ferritin'
named entity 'ECMO'
named entity 'LDH'
named entity 'supplemental oxygen'
named entity 'obesity'
named entity 'tocilizumab'
named entity 'antagonist'
named entity 'tocilizumab'
named entity 'off-label'
named entity 'tocilizumab'
named entity 'Infection'
named entity 'lung'
named entity 'comorbidity'
named entity 'IL-1 receptor antagonist'
named entity 'tocilizumab'
named entity 'immunomodulatory'
named entity 'viral infections'
named entity 'CRS'
named entity 'adverse effects'
named entity 'COVID'
named entity 'monotherapy'
named entity 'SOFA score'
named entity 'amylase'
named entity 'supplemental oxygen'
named entity 'SOFA score'
named entity 'ritonavir'
named entity 'tocilizumab'
named entity 'symptom'
named entity 'chest radiograph'
named entity 'IBM'
named entity 'SOFA score'
named entity 'tocilizumab'
named entity 'SOFA score'
named entity 'symptom'
named entity 'off-label'
named entity 'IL-6'
named entity 'chi-squared test'
named entity 'acute respiratory distress syndrome'
named entity 'IL-6 receptor'
named entity 'retrospective cohort study'
named entity '7-11'
named entity 'SOFA score'
named entity 'sample size'
named entity 'host response'
named entity 'Pharmacologic treatment'
named entity 'multivariate regression model'
named entity 'tocilizumab'
named entity 'clinical symptoms'
named entity 'tocilizumab'
named entity 'tocilizumab'
named entity 'LDH'
named entity 'invasive mechanical ventilation'
named entity 'supplemental oxygen'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software